Found 3 Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase BTK' and Ligand = 'BDBM348286' TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Sunesis Pharmaceuticals, Inc.; Biogen MA Inc.
US Patent
Sunesis Pharmaceuticals, Inc.; Biogen MA Inc.
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The purpose of the BTK in vitro assay is to determine compound potency against BTK through the measurement of IC50. Compound inhibition is measured a...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Sunesis Pharmaceuticals, Inc.; Biogen MA Inc.
US Patent
Sunesis Pharmaceuticals, Inc.; Biogen MA Inc.
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:BTK-POLYGAT-LS ASSAY. The purpose of the BTK in vitro assay is to determine compound potency against BTK through the measurement of IC50. Compound in...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Sunesis Pharmaceuticals, Inc.; Biogen MA Inc.
US Patent
Sunesis Pharmaceuticals, Inc.; Biogen MA Inc.
US Patent
Affinity DataIC50: 4.50E+4nMAssay Description:Reversible inhibition of recombinant full-length N-terminal 6-His-tagged human BTK expressed in baculovirus infected Sf21 insect cells using fluoresc...More data for this Ligand-Target Pair
